Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Antimicrobial activity of cefepime-tazobactam combination against extended spectrum beta-lactamase and/or AmpC beta-lactamase- producing gram-negative bacilli

Fig. 2

Confirmation of ESBL production by combined disc method and confirmation of AmpC production by by AmpC disc

(A): Confirmation of ESBL production by the combined disc method: an ESBL-producing E. coli isolate showing ˃ 5 mm difference in zone diameter between ceftazidime (CAZ) and ceftazidime plus clavulanic acid (CCAZ).

(B): Confirmation of AmpC production by AmpC disc in a K. pneumoniae isolate; there is flattening in the cefoxitin (FOX) inhibitory zone (arrow)

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us